Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Sep;55(9):603–606. doi: 10.1136/ard.55.9.603

Increased capillary permeability in systemic sclerosis: help or hindrance?

W Grassi 1, P Core 1, C Cervini 1
PMCID: PMC1010253  PMID: 8882128

Full text

PDF
603

Images in this article

603Image
on p.603
605Image
on p.605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black C. M. The aetiopathogenesis of systemic sclerosis. J Intern Med. 1993 Jul;234(1):3–8. doi: 10.1111/j.1365-2796.1993.tb00697.x. [DOI] [PubMed] [Google Scholar]
  2. Bollinger A., Frey J., Jäger K., Furrer J., Seglias J., Siegenthaler W. Patterns of diffusion through skin capillaries in patients with long-term diabetes. N Engl J Med. 1982 Nov 18;307(21):1305–1310. doi: 10.1056/NEJM198211183072103. [DOI] [PubMed] [Google Scholar]
  3. Bollinger A., Jäger K., Roten A., Timeus C., Mahler F. Diffusion, pericapillary distribution and clearance of Na-fluorescein in the human nailfold. Pflugers Arch. 1979 Nov;382(2):137–143. doi: 10.1007/BF00584215. [DOI] [PubMed] [Google Scholar]
  4. Bollinger A., Jäger K., Siegenthaler W. Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy. Arch Intern Med. 1986 Aug;146(8):1541–1545. [PubMed] [Google Scholar]
  5. Colwell J. A., Halushka P. V., Sarji K. E., Lopes-Virella M. F., Sagel J. Vascular disease in diabetes: pathophysiological mechanisms and therapy. Arch Intern Med. 1979 Feb;139(2):225–230. [PubMed] [Google Scholar]
  6. Cooke E. D., Nicolaides A. N. Raynaud's syndrome. BMJ. 1990 Mar 3;300(6724):553–555. doi: 10.1136/bmj.300.6724.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DeBure C., Fiessinger J. N., Priollet P., Camilleri J. P., Vayssairat M., Kazandjian S., Housset E. Relationship between nailfold capillary microscopy and salivary capillary basement membrane width in Raynaud's disease and progressive systemic sclerosis. J Rheumatol. 1985 Apr;12(2):279–282. [PubMed] [Google Scholar]
  8. Ditzel J. Oxygen transport impairment in diabetes. Diabetes. 1976;25(2 Suppl):832–838. [PubMed] [Google Scholar]
  9. Duboc D., Kahan A., Maziere B., Loc'h C., Crouzel C., Menkès C. J., Amor B., Strauch G., Guérin F., Syrota A. The effect of nifedipine on myocardial perfusion and metabolism in systemic sclerosis. A positron emission tomographic study. Arthritis Rheum. 1991 Feb;34(2):198–203. doi: 10.1002/art.1780340211. [DOI] [PubMed] [Google Scholar]
  10. Farah M. J., Palmieri G. M., Sebes J. I., Cremer M. A., Massie J. D., Pinals R. S. The effect of diltiazem on calcinosis in a patient with the CREST syndrome. Arthritis Rheum. 1990 Aug;33(8):1287–1293. doi: 10.1002/art.1780330834. [DOI] [PubMed] [Google Scholar]
  11. Fleischmajer R., Perlish J. S., Shaw K. V., Pirozzi D. J. Skin capillary changes in early systemic scleroderma. Electron microscopy and "in vitro" autoradiography with tritiated thymidine. Arch Dermatol. 1976 Nov;112(11):1553–1557. [PubMed] [Google Scholar]
  12. Goodfield M. J., Rowell N. R. Hand warming as a treatment for Raynaud's phenomenon in systemic sclerosis. Br J Dermatol. 1988 Nov;119(5):643–646. doi: 10.1111/j.1365-2133.1988.tb03477.x. [DOI] [PubMed] [Google Scholar]
  13. Grassi W., Core P., Carlino G., Blasetti P., Cervini M. Labial capillary microscopy in systemic sclerosis. Ann Rheum Dis. 1993 Aug;52(8):564–569. doi: 10.1136/ard.52.8.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Grassi W., Core P., Carlino G., Cervini C. Acute effects of single dose nifedipine on cold-induced changes of microvascular dynamics in systemic sclerosis. Br J Rheumatol. 1994 Dec;33(12):1154–1161. doi: 10.1093/rheumatology/33.12.1154. [DOI] [PubMed] [Google Scholar]
  15. Grassi W., Core P., Carlino G., Cervini C. Effects of peripheral cold exposure on microvascular dynamics in systemic sclerosis. Arthritis Rheum. 1994 Mar;37(3):384–390. doi: 10.1002/art.1780370312. [DOI] [PubMed] [Google Scholar]
  16. Grassi W., Core P., Carlino G., Cervini C. Nailfold capillary permeability in psoriatic arthritis. Scand J Rheumatol. 1992;21(5):226–230. doi: 10.3109/03009749209099229. [DOI] [PubMed] [Google Scholar]
  17. Grassi W., Felder M., Thüring-Vollenweider U., Bollinger A. Microvascular dynamics at the nailfold in rheumatoid arthritis. Clin Exp Rheumatol. 1989 Jan-Feb;7(1):47–53. [PubMed] [Google Scholar]
  18. Grassi W., Gasparini M., Cervini C. Nailfold computed videomicroscopy in morpho-functional assessment of diabetic microangiopathy. Acta Diabetol Lat. 1985 Jul-Sep;22(3):223–228. doi: 10.1007/BF02590773. [DOI] [PubMed] [Google Scholar]
  19. Gustafsson R., Mannting F., Kazzam E., Waldenström A., Hällgren R. Cold-induced reversible myocardial ischaemia in systemic sclerosis. Lancet. 1989 Aug 26;2(8661):475–479. doi: 10.1016/s0140-6736(89)92088-6. [DOI] [PubMed] [Google Scholar]
  20. Houtman P. M., Kallenberg C. G., Wouda A. A., The T. H. Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease? Ann Rheum Dis. 1985 Sep;44(9):603–609. doi: 10.1136/ard.44.9.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jaffe I. A. Nifedipine in digital ulceration in scleroderma. Arthritis Rheum. 1982 Oct;25(10):1267–1269. doi: 10.1002/art.1780251019. [DOI] [PubMed] [Google Scholar]
  22. Jayson M. I., Holland C. D., Keegan A., Illingworth K., Taylor L. A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis. Ann Rheum Dis. 1991 Jan;50(1):41–47. doi: 10.1136/ard.50.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Jayson M. I. Systemic sclerosis--a microvascular disorder? J R Soc Med. 1983 Aug;76(8):635–642. doi: 10.1177/014107688307600804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jayson M. I. The micro-circulation in systemic sclerosis. Clin Exp Rheumatol. 1984 Jan-Mar;2(1):85–91. [PubMed] [Google Scholar]
  25. Kahaleh M. B., Osborn I., LeRoy E. C. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon. Ann Intern Med. 1981 Apr;94(4 Pt 1):482–484. doi: 10.7326/0003-4819-94-4-482. [DOI] [PubMed] [Google Scholar]
  26. Kahan A., Amor B., Menkes C. J., Weber S. Nifedipine in digital ulceration in scleroderma. Arthritis Rheum. 1983 Jun;26(6):809–809. doi: 10.1002/art.1780260620. [DOI] [PubMed] [Google Scholar]
  27. Kahan A., Devaux J. Y., Amor B., Menkès C. J., Weber S., Nitenberg A., Venot A., Guérin F., Degeorges M., Roucayrol J. C. Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. N Engl J Med. 1986 May 29;314(22):1397–1402. doi: 10.1056/NEJM198605293142201. [DOI] [PubMed] [Google Scholar]
  28. LeRoy E. C. A brief overview of the pathogenesis of scleroderma (systemic sclerosis). Ann Rheum Dis. 1992 Feb;51(2):286–288. doi: 10.1136/ard.51.2.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. LeRoy E. C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T. A., Jr, Rowell N., Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988 Feb;15(2):202–205. [PubMed] [Google Scholar]
  30. Leroy E. C., Smith E. A., Kahaleh M. B., Trojanowska M., Silver R. M. A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer? Arthritis Rheum. 1989 Jul;32(7):817–825. [PubMed] [Google Scholar]
  31. Mahler F., Saner H., Boss C., Annaheim M. Local cold exposure test for capillaroscopic examination of patients with Raynaud's syndrome. Microvasc Res. 1987 May;33(3):422–427. doi: 10.1016/0026-2862(87)90033-1. [DOI] [PubMed] [Google Scholar]
  32. Maricq H. R., Downey J. A., LeRoy E. C. Standstill of nailfold capillary blood flow during cooling in scleroderma and Raynaud's syndrome. Blood Vessels. 1976;13(6):338–349. doi: 10.1159/000158104. [DOI] [PubMed] [Google Scholar]
  33. Maricq H. R., Maize J. C. Nailfold capillary abnormalities. Clin Rheum Dis. 1982 Aug;8(2):455–478. [PubMed] [Google Scholar]
  34. Maricq H. R. Wide-field capillary microscopy. Arthritis Rheum. 1981 Sep;24(9):1159–1165. doi: 10.1002/art.1780240907. [DOI] [PubMed] [Google Scholar]
  35. Medsger T. A., Jr Treatment of systemic sclerosis. Ann Rheum Dis. 1991 Nov;50 (Suppl 4):877–886. doi: 10.1136/ard.50.suppl_4.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rothschild B. M., Masi A. T. Pathogenesis of rheumatoid arthritis: a vascular hypothesis. Semin Arthritis Rheum. 1982 Aug;12(1):11–31. doi: 10.1016/0049-0172(82)90020-8. [DOI] [PubMed] [Google Scholar]
  37. Seibold J. R. Critical tissue ischaemia in scleroderma: a note of caution. Ann Rheum Dis. 1994 May;53(5):289–290. doi: 10.1136/ard.53.5.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Seibold J. R. Serotonin and Raynaud's phenomenon. J Cardiovasc Pharmacol. 1985;7 (Suppl 7):S95–S98. [PubMed] [Google Scholar]
  39. Sfikakis P. P., Kyriakidis M. K., Vergos C. G., Vyssoulis G. P., Psarros T. K., Kyriakidis C. A., Mavrikakis M. E., Sfikakis P. P., Toutouzas P. K. Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril. Am J Med. 1991 May;90(5):541–546. [PubMed] [Google Scholar]
  40. Sfikakis P. P., Kyriakidis M., Vergos C., Papazoglou S., Georgiakodis F., Toutouzas P., Sfikakis P. Diffusing capacity of the lung and nifedipine in systemic sclerosis. Arthritis Rheum. 1990 Nov;33(11):1634–1639. doi: 10.1002/art.1780331105. [DOI] [PubMed] [Google Scholar]
  41. Shuck J. W., Oetgen W. J., Tesar J. T. Pulmonary vascular response during Raynaud's phenomenon in progressive systemic sclerosis. Am J Med. 1985 Feb;78(2):221–227. doi: 10.1016/0002-9343(85)90430-9. [DOI] [PubMed] [Google Scholar]
  42. Tsianos E. V., Berecos C., Stavropoulos E., Kazazis E., Danielides I. C., Drosos A. A. The effects of peripheral cold exposure on oesophageal motility in patients with autoimmune rheumatic diseases and Raynaud's phenomenon. Clin Rheumatol. 1991 Sep;10(3):311–315. doi: 10.1007/BF02208697. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES